Prognostic value of plasma Epstein-Barr virus DNA level during posttreatment follow-up in the patients with nasopharyngeal carcinoma having undergone intensity-modulated radiotherapy.

Wen-Fei LiYuan ZhangXiao-Bin HuangXiao-Jing DuLing-Long TangLei ChenHao PengRui GuoYing SunJun Ma

Published in: Chinese journal of cancer (2017)

Plasma EBV DNA level during posttreatment follow-up is a good marker for predicting distant metastasis but not locoregional recurrence in the patients with NPC irrespective of the pretreatment EBV DNA levels.

Keyphrases

epstein barr virus
circulating tumor
diffuse large b cell lymphoma
cell free
single molecule
early stage
nucleic acid
lymph node
radiation therapy
circulating tumor cells
locally advanced
free survival